RETATRUTIDE 10MG-User Manual & Research Protocol Guide

• Compound: Retatrutide
• Strength: 10 mg per vial
• Form: Lyophilized powder
• Category: GLP-1 / GIP / Glucagon Receptor Agonist (Research)
• Intended Use: Laboratory research purposes only
• Storage (Unmixed): Store refrigerated at 2–8°C
• Storage (After Reconstitution): Refrigerate and use within 30 days

Retatrutide is studied as a triple receptor agonist, targeting:

• GLP-1 receptor – Appetite & glucose regulation
• GIP receptor – Metabolic modulation
• Glucagon receptor – Energy expenditure support

This multi-pathway activity is being researched for metabolic and body composition studies.

Supplies Needed

• Bacteriostatic Water
• Alcohol swabs
• Insulin syringe (U-100)
• Sterile technique

Step-by-Step Reconstitution

1. Sanitize vial tops with alcohol swab.
2. Draw desired amount of bacteriostatic water.
3. Slowly inject water down the inside wall of the vial.
4. Gently swirl until fully dissolved.
   ❗ Do NOT shake.

(Research Structure Reference Only – Not Medical Advice)

Option 1: Add 2 mL Bacteriostatic Water

• Total Peptide: 10 mg
• Final Concentration: 5 mg per mL
  

U-100 Insulin Syringe Conversion:

• 10 units → 0.1 mL → 0.5 mg
• 20 units → 0.2 mL → 1 mg
• 30 units → 0.3 mL → 1.5 mg
• 40 units → 0.4 mL → 2 mg
• 50 units → 0.5 mL → 2.5 mg

Option 2: Add 1 mL Bacteriostatic Water

• Final Concentration: 10 mg per mL
  

U-100 Insulin Syringe Conversion:

• 5 units → 0.05 mL → 0.5 mg
• 10 units → 0.1 mL → 1 mg
• 20 units → 0.2 mL → 2 mg

• Frequently studied as once-weekly subcutaneous administration
• Gradual titration models often evaluated in research settings
• Observation period typically 8–24 weeks in study environments

• For laboratory research use only
• Not for human consumption
• Not FDA approved for therapeutic use
• Use sterile handling procedures
• Keep refrigerated
• Keep out of reach of children